PNC Financial Services Group’s Neurogene NGNE Stock Holding History

PNC Financial Services Group’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.95K	Sell	178 -4,323	-96%	-$154K	﹤0.01%	4513
2026 Q2	$142K	Sell	4,501 -546	-11%	-$15K	﹤0.01%	2698
2026 Q1	$102K	Sell	5,047 -77	-2%	-$1.49K	﹤0.01%	2805
2025 Q4	$106K	Buy	5,124 +69	+1%	+$1.72K	﹤0.01%	2769
2025 Q3	$87.6K	Buy	5,055 +1,000	+25%	+$20.1K	﹤0.01%	2896
2025 Q2	$60.6K	Buy	4,055 +1,232	+44%	+$19.3K	﹤0.01%	3006
2025 Q1	$33.1K	Sell	2,823 -303	-10%	-$5.26K	﹤0.01%	3311
2024 Q4	$71.5K	Buy	+3,126	New	+$116K	﹤0.01%	2895

Other funds holding NGNE

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Tyro Capital Management Miami, Florida $564M AUM 72.37% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

PNC Financial Services Group's NGNE Position: Q3 2026 in Review

PNC Financial Services Group reduced its Neurogene (NGNE) stake by 96% in Q3 2026, selling an estimated $154K and leaving 178 shares worth $4.95K. The position accounts for ﹤0.01% of the portfolio, ranked #4513.

PNC Financial Services Group first reported a position in NGNE in Q4 2024 and has held it in 8 quarters since. The position peaked at $142K in Q2 2026. 61 funds tracked by Wall St. Rank hold NGNE as of Q3 2026.

PNC Financial Services Group held 178 shares of Neurogene worth $4.95K as of Q3 2026.
PNC Financial Services Group sold 4,323 Neurogene shares in Q3 2026, an estimated $154K.
Neurogene made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4513 holding.
PNC Financial Services Group first reported a position in Neurogene in Q4 2024 and has held it in 8 quarters since.
PNC Financial Services Group's Neurogene position peaked at $142K in Q2 2026.
61 funds tracked by Wall St. Rank held Neurogene as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.